AGM/EGMJul 16, 2026, 04:41 PM
Indaptus Therapeutics Sets 2026 Annual Meeting Agenda
AI Summary
Indaptus Therapeutics, Inc. announced its 2026 Annual Meeting of Stockholders to be held virtually on August 10, 2026. Stockholders will vote on the election of three Class II directors, the ratification of Haskell & White LLP as the independent auditor for fiscal year 2026, and the approval of the 2026 Equity Incentive Plan. The new equity plan proposes an initial reserve of approximately 13.3 million shares and an annual increase provision.
Key Highlights
- Annual Meeting of Stockholders scheduled for August 10, 2026, at 10:00 a.m. Eastern Time.
- Stockholders will vote on the election of three Class II directors: David Natan, Tim Ruan, and Johnny Fox Arrowsmith.
- Proposal to ratify Haskell & White LLP as the independent registered public accounting firm for fiscal year 2026.
- Proposal to approve the Indaptus Therapeutics, Inc. 2026 Equity Incentive Plan.
- The 2026 Equity Incentive Plan will initially reserve 10% of outstanding common stock, approximately 13,324,232 shares.
- The 2026 Plan includes an automatic annual increase of 5% of outstanding common stock from 2027 to 2031.
- The 2021 Stock Incentive Plan will be terminated for future grants upon approval of the 2026 Plan.
- Record date for voting is June 12, 2026, with 113,242,324 shares of common stock outstanding.
Price Impact
More from INDP